Clinical Trial Update: A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This is a first-in-human trial of DS3790a in participants with hematologic malignancies. The study is currently recruiting for Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• DS3790a

Snippet

Sponsor: Daiichi Sankyo | Conditions: Hematological Malignancies | Phase 1, Phase 2 | Status: RECRUITING